Heart Disease News and Research

Latest Heart Disease News and Research

CAMH embarks on next phase of landmark redevelopment project

The Centre for Addiction and Mental Health is making history. On April 6, CAMH is breaking ground on the next phase of its landmark redevelopment project, transforming the site of what was originally the 1850 Provincial Lunatic Asylum into a modern, welcoming 'urban village' in the heart of Queen Street West. Nothing quite like this has ever been done before.

31 Mar 2010

Haiti's recovery: CARE calls for substantial, sustained commitment from international community

At this week's International Donors' Conference Towards a New Future for Haiti (March 31, 2010), CARE will urge the international community to ensure all Haitians have a chance to rebuild their country anew. Women and girls, in particular, will be at the heart of CARE's policy recommendations to address Haiti's recovery, reconstruction and long-term development needs as donor countries, international organizations and other partners gather to pledge resources and commit to long-term efforts in Haiti following the devastating January earthquake.

31 Mar 2010

Nation's emergency physicians warn parents about dangers of prescription drug abuse

The nation's emergency physicians are issuing a strong warning to parents about the dangers of prescription drug abuse, which are now the second most abused drugs, after marijuana. Nearly three-quarters of a million people (741,425) needed emergency care in 2006 because of prescription drug abuse.

31 Mar 2010

Fat-rich breakfast may help prevent metabolic syndrome, says study

The age-old maxim "Eat breakfast like a king, lunch like a prince and dinner like a pauper" may in fact be the best advice to follow to prevent metabolic syndrome, according to a new University of Alabama at Birmingham (UAB) study.

31 Mar 2010

Cryo-Cell International, MOSI partner to develop educational exhibit on stem cells and regenerative science

Cryo-Cell International Inc., a global leader of innovative stem cell solutions and stem cell cryopreservation services, today announced plans to partner with Museum of Science & Industry (MOSI) in the development and launch of an interactive educational exhibit on stem cells and regenerative science. Cryo-Cell is one of the most established private family cord blood banks and is a pioneer in the stem cell industry.

31 Mar 2010

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

When President Obama signed the Patient Protection and Affordable Care Act into law, he ushered in dramatic health care reforms unparalleled since the days of Franklin Delano Roosevelt's New Deal. On April 8, two of the nation's foremost employee benefits and health care law experts from Sonnenschein Nath & Rosenthal LLP, Bruce Fried and Martin Moderson, will present a BNA Tax & Accounting webinar, Health Care Reform – Preparing Employers and Health Plans, directed to professionals who advise employers large and small on employee health care benefits or work with ERISA or non-ERISA health plans.

31 Mar 2010

Vidazorb probiotic supplements could minimize severity of IBS symptoms

April is Irritable Bowel Syndrome (IBS) Awareness Month. IBS is a chronic condition affecting between 15 and 20 percent of all adults in the Western world. However, IBS is difficult to identify due to the numerous symptoms associated with it. Almost 40 percent of IBS sufferers report symptoms severe and frequent enough to disrupt their daily lives, making it is a serious issue—one to which Vidazorb® probiotic supplements may offer some relief.

31 Mar 2010

PhRMA report: 234 medicines in development for special health care needs of children

America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.

31 Mar 2010

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Bioheart, Inc., announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure.

31 Mar 2010

HHMI awards 2010 Gilliam Fellowship to UT Southwestern student

Mariam El-Ashmawy, a student enrolled in UT Southwestern Medical Center's prestigious Medical Scientist Training Program, has been awarded a 2010 Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute (HHMI).

31 Mar 2010

New anti-inflammatory drug shows promise for treating inflammatory disorders

Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders. But despite their widespread use (around 2.5 million Canadians have osteoarthritis) these medications are also known to cause severe, sometimes life-threatening adverse effects within the body, particularly in the gastrointestinal tract

31 Mar 2010

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Eating foods containing flavonoids -- orange juice, in this case -- along with a high-fat, high-carbohydrate fast-food meal neutralizes the oxidative and inflammatory stress generated by the unhealthy food and helps prevent blood vessel damage, a new study by University at Buffalo endocrinologists shows.

31 Mar 2010

PolyMedix completes Phase 1B clinical study with PMX-30063 defensin-mimetic antibiotic

PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.

31 Mar 2010

Likeley CMS pick Berwick has big ideas on fixing U.S. health care delivery

Dr. Donald Berwick is reportedly the president's choice to run the Centers for Medicare and Medicaid.

31 Mar 2010

NKF 2010 Spring Clinical Meeting: Multiple posters on Hematide/peginesatide to be presented

Affymax, Inc. and Takeda Pharmaceuticals Global Research & Development Center, Inc., U.S., today announced multiple posters on Hematide™/peginesatide have been accepted for presentation at the National Kidney Foundation (NKF) 2010 Spring Clinical Meeting taking place April 13-17, 2010 in Orlando, Florida. Hematide is an investigational agent for the treatment of anemia in chronic renal failure (also referred to as renal anemia).

31 Mar 2010

CryoLife files emergency motion for preliminary injunction against Medafor

CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it filed an emergency motion for a preliminary injunction against Medafor, Inc. in the United States District Court for the Northern District of Georgia, Atlanta division. CryoLife contends that Medafor is improperly attempting to terminate the exclusive distribution agreement ("EDA") between the parties, and CryoLife has requested that the Court enjoin Medafor from proceeding with the termination.

31 Mar 2010

Hsp90 inhibitors may help fight cardiovascular disease, say researchers

New drugs that are helping fight a multi-front war on cancer may do the same for cardiovascular disease, Medical College of Georgia researchers said.

31 Mar 2010

Cambridge Heart's fourth-quarter total revenue down 20%

Cambridge Heart, Inc., today reported results for its fourth quarter and year ended December 31, 2009. Full financial statements and corresponding commentary can be found in the Company's Form 10-K, which is expected to be filed with the Securities and Exchange Commission on March 31, 2010.

31 Mar 2010

Reverse Medical closes Series-B private equity financing

Reverse Medical Corporation announced today the closing of their Series-B private equity financing. The Company raised $14 million from new investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners.

31 Mar 2010

Asclera injection receives FDA approval

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

31 Mar 2010

Heart Disease News and Research

Latest Heart Disease News and Research

CAMH embarks on next phase of landmark redevelopment project

Haiti's recovery: CARE calls for substantial, sustained commitment from international community

Nation's emergency physicians warn parents about dangers of prescription drug abuse

Fat-rich breakfast may help prevent metabolic syndrome, says study

Cryo-Cell International, MOSI partner to develop educational exhibit on stem cells and regenerative science

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

Vidazorb probiotic supplements could minimize severity of IBS symptoms

PhRMA report: 234 medicines in development for special health care needs of children

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

HHMI awards 2010 Gilliam Fellowship to UT Southwestern student

New anti-inflammatory drug shows promise for treating inflammatory disorders

Drinking orange juice with fast-food meal may help prevent vascular inflammation

PolyMedix completes Phase 1B clinical study with PMX-30063 defensin-mimetic antibiotic

Likeley CMS pick Berwick has big ideas on fixing U.S. health care delivery

NKF 2010 Spring Clinical Meeting: Multiple posters on Hematide/peginesatide to be presented

CryoLife files emergency motion for preliminary injunction against Medafor

Hsp90 inhibitors may help fight cardiovascular disease, say researchers

Cambridge Heart's fourth-quarter total revenue down 20%

Reverse Medical closes Series-B private equity financing

Asclera injection receives FDA approval

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in